Trial no.:
|
PACTR202310555394577 |
Date of Approval:
|
13/10/2023 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Quality of Life in Children with Carotid Intima-Medial Thickness after Juvenile diabetes |
Official scientific title |
Quality of Life in Children with Carotid Intima-Medial Thickness after Juvenile diabetes |
Brief summary describing the background
and objectives of the trial
|
Intimo-medial thickness (IMT) is a measure of the combined thickness of intima and media layers of carotid artery, most commonly assessed by B-mode ultrasound. Increase in carotid intima–media thickness (CIMT) may result from hypertrophy of intimal or medial layers or both because cellular/molecular mechanisms that increase CIMT are also the factors responsible for development and progression of atherosclerosis. The purpose of this study was to investigate the impact of carotid intima- medial thickness on quality of life of children after juvenile diabetes. |
Type of trial |
Observational |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Cardiology,Circulatory System,Haematological Disorders,Nutritional, Metabolic, Endocrine,Paediatrics |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Diagnosis / Prognosis |
Anticipated trial start date |
16/02/2023 |
Actual trial start date |
30/04/2023 |
Anticipated date of last follow up |
10/05/2023 |
Actual Last follow-up date |
31/05/2023 |
Anticipated target sample size (number of participants) |
90 |
Actual target sample size (number of participants) |
90 |
Recruitment status |
Completed |
Publication URL |
|
|